BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 21922173)

  • 1. Neuromyelitis Optica-AQP4: an update.
    Benavente E; Paira S
    Curr Rheumatol Rep; 2011 Dec; 13(6):496-505. PubMed ID: 21922173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease.
    Magaña SM; Pittock SJ; Lennon VA; Keegan BM; Weinshenker BG; Lucchinetti CF
    Arch Neurol; 2009 Aug; 66(8):964-6. PubMed ID: 19667216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optic neuritis in neuromyelitis optica.
    Levin MH; Bennett JL; Verkman AS
    Prog Retin Eye Res; 2013 Sep; 36():159-71. PubMed ID: 23545439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expanded spectrum of neuromyelitis optica: evidences for a new definition.
    Lana-Peixoto MA; Callegaro D
    Arq Neuropsiquiatr; 2012 Oct; 70(10):807-13. PubMed ID: 23060108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
    Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W
    Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromyelitis optica: clinical features, immunopathogenesis and treatment.
    Jarius S; Wildemann B; Paul F
    Clin Exp Immunol; 2014 May; 176(2):149-64. PubMed ID: 24666204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese.
    Chan KH; Ramsden DB; Yu YL; Kwok KH; Chu AC; Ho PW; Kwan JS; Lee R; Lim E; Kung MH; Ho SL
    Eur J Neurol; 2009 Mar; 16(3):310-6. PubMed ID: 19138340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders.
    Jacob A; McKeon A; Nakashima I; Sato DK; Elsone L; Fujihara K; de Seze J
    J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):922-30. PubMed ID: 23142960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic value of aquaporin-4 antibody in patients of inflammatory demyelinating diseases in central nervous system].
    Yang Y; Wu WP; Huang DH; Wu L
    Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(43):3032-5. PubMed ID: 23328372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromyelitis Optica (Devic's Syndrome): an Appraisal.
    Crout TM; Parks LP; Majithia V
    Curr Rheumatol Rep; 2016 Aug; 18(8):54. PubMed ID: 27402111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Devic's neuromyelitis optica: a critical review.
    Lana-Peixoto MA
    Arq Neuropsiquiatr; 2008 Mar; 66(1):120-38. PubMed ID: 18392436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuromyelitis optica is a frequently seen inflammatory demyelinating disease].
    Asgari N; Skejø HP; Lillevang ST; Stenager E
    Ugeskr Laeger; 2013 May; 175(19):1331-5. PubMed ID: 23663369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
    Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
    J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromyelitis optica.
    Wingerchuk DM
    Int MS J; 2006 May; 13(2):42-50. PubMed ID: 16635421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
    Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
    JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromyelitis optica: diagnosis, pathogenesis, and treatment.
    Cree B
    Curr Neurol Neurosci Rep; 2008 Sep; 8(5):427-33. PubMed ID: 18713580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature.
    Jarius S; Wildemann B
    Brain Pathol; 2013 Nov; 23(6):661-83. PubMed ID: 24118483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMO-IgG: a specific biomarker for neuromyelitis optica.
    Weinshenker BG; Wingerchuk DM; Pittock SJ; Lucchinetti CF; Lennon VA
    Dis Markers; 2006; 22(4):197-206. PubMed ID: 17124341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and classification of neuromyelitis optica (Devic's syndrome).
    Drori T; Chapman J
    Autoimmun Rev; 2014; 13(4-5):531-3. PubMed ID: 24424197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].
    Misu T; Fujihara K; Itoyama Y
    Brain Nerve; 2008 May; 60(5):527-37. PubMed ID: 18516975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.